Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 146 entries
Sorted by: Best Match Show Resources per page
Infective endocarditis in patients with liver cirrhosis: a systematic review.

Journal of chemotherapy (Florence, Italy)

Ioannou P, Savva E, Kofteridis DP.
PMID: 33512305
J Chemother. 2021 Nov;33(7):443-451. doi: 10.1080/1120009X.2021.1878332. Epub 2021 Jan 29.

Liver cirrhosis is an increasing cause of mortality and morbidity in developed countries. Infective Endocarditis (IE) is an uncommon disease with notable morbidity and mortality. Even though cirrhosis is associated with immune dysfunction and increased occurrence of bacterial infection,...

Cite
Ioannou P, Savva E, Kofteridis DP. Infective endocarditis in patients with liver cirrhosis: a systematic review. J Chemother. 2021;33(7):443-451doi: 10.1080/1120009X.2021.1878332.
Ioannou, P., Savva, E., & Kofteridis, D. P. (2021). Infective endocarditis in patients with liver cirrhosis: a systematic review. Journal of chemotherapy (Florence, Italy), 33(7), 443-451. https://doi.org/10.1080/1120009X.2021.1878332
Ioannou, Petros, et al. "Infective endocarditis in patients with liver cirrhosis: a systematic review." Journal of chemotherapy (Florence, Italy) vol. 33,7 (2021): 443-451. doi: https://doi.org/10.1080/1120009X.2021.1878332
Ioannou P, Savva E, Kofteridis DP. Infective endocarditis in patients with liver cirrhosis: a systematic review. J Chemother. 2021 Nov;33(7):443-451. doi: 10.1080/1120009X.2021.1878332. Epub 2021 Jan 29. PMID: 33512305.
Copy Download .nbib Format: NLM
Urinary tract infection in a human male patient with .

Journal of chemotherapy (Florence, Italy)

Blondeau LD, Deutscher M, Rubin JE, Deneer H, Kanthan R, Sanche S, Blondeau JM.
PMID: 34747350
J Chemother. 2021 Nov 08;1-4. doi: 10.1080/1120009X.2021.1995251. Epub 2021 Nov 08.

No abstract available.

Cite
Blondeau LD, Deutscher M, Rubin JE, et al. Urinary tract infection in a human male patient with . J Chemother. 2021;1-4doi: 10.1080/1120009X.2021.1995251.
Blondeau, L. D., Deutscher, M., Rubin, J. E., Deneer, H., Kanthan, R., Sanche, S., & Blondeau, J. M. (2021). Urinary tract infection in a human male patient with . Journal of chemotherapy (Florence, Italy), 1-4. https://doi.org/10.1080/1120009X.2021.1995251
Blondeau, L D, et al. "Urinary tract infection in a human male patient with ." Journal of chemotherapy (Florence, Italy) vol. (2021): 1-4. doi: https://doi.org/10.1080/1120009X.2021.1995251
Blondeau LD, Deutscher M, Rubin JE, Deneer H, Kanthan R, Sanche S, Blondeau JM. Urinary tract infection in a human male patient with . J Chemother. 2021 Nov 08;1-4. doi: 10.1080/1120009X.2021.1995251. Epub 2021 Nov 08. PMID: 34747350.
Copy Download .nbib Format: NLM
Antibiotic susceptibility of .

Journal of chemotherapy (Florence, Italy)

Lezzi M, Bandettini R, Ugolotti E, Saffioti C, Mesini A, Pastorino C, Manunza F, Ferretti M, Brisca G, Castagnola E.
PMID: 33272149
J Chemother. 2021 Oct;33(6):361-364. doi: 10.1080/1120009X.2020.1852832. Epub 2020 Dec 04.

Antibiotic susceptibility of

Cite
Lezzi M, Bandettini R, Ugolotti E, et al. Antibiotic susceptibility of . J Chemother. 2020;33(6):361-364doi: 10.1080/1120009X.2020.1852832.
Lezzi, M., Bandettini, R., Ugolotti, E., Saffioti, C., Mesini, A., Pastorino, C., Manunza, F., Ferretti, M., Brisca, G., & Castagnola, E. (2021). Antibiotic susceptibility of . Journal of chemotherapy (Florence, Italy), 33(6), 361-364. https://doi.org/10.1080/1120009X.2020.1852832
Lezzi, Marilea, et al. "Antibiotic susceptibility of ." Journal of chemotherapy (Florence, Italy) vol. 33,6 (2021): 361-364. doi: https://doi.org/10.1080/1120009X.2020.1852832
Lezzi M, Bandettini R, Ugolotti E, Saffioti C, Mesini A, Pastorino C, Manunza F, Ferretti M, Brisca G, Castagnola E. Antibiotic susceptibility of . J Chemother. 2021 Oct;33(6):361-364. doi: 10.1080/1120009X.2020.1852832. Epub 2020 Dec 04. PMID: 33272149.
Copy Download .nbib Format: NLM
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration.

Journal of chemotherapy (Florence, Italy)

Sazanami K, Inose R, Dote S, Horiuchi N, Kobayashi Y, Muraki Y.
PMID: 33222657
J Chemother. 2021 Oct;33(6):440-442. doi: 10.1080/1120009X.2020.1848298. Epub 2020 Nov 23.

No abstract available.

Cite
Sazanami K, Inose R, Dote S, et al. Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration. J Chemother. 2020;33(6):440-442doi: 10.1080/1120009X.2020.1848298.
Sazanami, K., Inose, R., Dote, S., Horiuchi, N., Kobayashi, Y., & Muraki, Y. (2021). Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration. Journal of chemotherapy (Florence, Italy), 33(6), 440-442. https://doi.org/10.1080/1120009X.2020.1848298
Sazanami, Kohei, et al. "Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration." Journal of chemotherapy (Florence, Italy) vol. 33,6 (2021): 440-442. doi: https://doi.org/10.1080/1120009X.2020.1848298
Sazanami K, Inose R, Dote S, Horiuchi N, Kobayashi Y, Muraki Y. Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration. J Chemother. 2021 Oct;33(6):440-442. doi: 10.1080/1120009X.2020.1848298. Epub 2020 Nov 23. PMID: 33222657.
Copy Download .nbib Format: NLM
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.

Journal of chemotherapy (Florence, Italy)

Ay S, Atcı MM, Arıkan R, Dülgar Ö, Özyükseler DT, Paksoy N, Doğan İ, Öztosun B, Taştekin D, Öven BB, Gümüş M.
PMID: 35037592
J Chemother. 2022 Jan 17;1-7. doi: 10.1080/1120009X.2022.2026125. Epub 2022 Jan 17.

Pancreas cancer (PCa) is one of the mortal cancer types with ranking as fourth leading cancer death in both sexes together. FOLFIRINOX (FFX) and Gemcitabine plus nab-paclitaxel (GNP) are approved as first-line metastatic treatment in PCa. The aim of...

Cite
Ay S, Atcı MM, Arıkan R, et al. FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. J Chemother. 2022;1-7doi: 10.1080/1120009X.2022.2026125.
Ay, S., Atcı, M. M., Arıkan, R., Dülgar, �. �., Özyükseler, D. T., Paksoy, N., Doğan, �. �., Öztosun, B., Taştekin, D., Öven, B. B., & Gümüş, M. (2022). FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. Journal of chemotherapy (Florence, Italy), 1-7. https://doi.org/10.1080/1120009X.2022.2026125
Ay, Seval, et al. "FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer." Journal of chemotherapy (Florence, Italy) vol. (2022): 1-7. doi: https://doi.org/10.1080/1120009X.2022.2026125
Ay S, Atcı MM, Arıkan R, Dülgar Ö, Özyükseler DT, Paksoy N, Doğan İ, Öztosun B, Taştekin D, Öven BB, Gümüş M. FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. J Chemother. 2022 Jan 17;1-7. doi: 10.1080/1120009X.2022.2026125. Epub 2022 Jan 17. PMID: 35037592.
Copy Download .nbib Format: NLM
C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells.

Journal of chemotherapy (Florence, Italy)

Gao YJ, Chen F, Zhang LJ.
PMID: 33825671
J Chemother. 2021 Nov;33(7):476-485. doi: 10.1080/1120009X.2021.1906035. Epub 2021 Apr 07.

This study aims to investigate the effects of C1q-like 1 (C1QL1) on the growth and migration of lung adenocarcinoma (LUAD) cells and the underlying mechanism. The expression of C1QL1 in LUAD tissues and its prognostic value were analyzed using...

Cite
Gao YJ, Chen F, Zhang LJ. C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells. J Chemother. 2021;33(7):476-485doi: 10.1080/1120009X.2021.1906035.
Gao, Y. J., Chen, F., & Zhang, L. J. (2021). C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells. Journal of chemotherapy (Florence, Italy), 33(7), 476-485. https://doi.org/10.1080/1120009X.2021.1906035
Gao, Yu-Jun, et al. "C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells." Journal of chemotherapy (Florence, Italy) vol. 33,7 (2021): 476-485. doi: https://doi.org/10.1080/1120009X.2021.1906035
Gao YJ, Chen F, Zhang LJ. C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells. J Chemother. 2021 Nov;33(7):476-485. doi: 10.1080/1120009X.2021.1906035. Epub 2021 Apr 07. PMID: 33825671.
Copy Download .nbib Format: NLM
Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, .

Journal of chemotherapy (Florence, Italy)

Ranjithkumar R, Saravanan K, Balaji B, Hima S, Sreeja S, Timane SR, Ram Pravin Kumar M, Kabilan S, Ramanathan M.
PMID: 34060437
J Chemother. 2021 Dec;33(8):582-594. doi: 10.1080/1120009X.2021.1924935. Epub 2021 Jun 01.

Eight novel ERβ selective daidzein analogues (NCE1-8) were synthesized and their anti-cancer activity was evaluated by

Cite
Ranjithkumar R, Saravanan K, Balaji B, et al. Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, . J Chemother. 2021;33(8):582-594doi: 10.1080/1120009X.2021.1924935.
Ranjithkumar, R., Saravanan, K., Balaji, B., Hima, S., Sreeja, S., Timane, S. R., Ram Pravin Kumar, M., Kabilan, S., & Ramanathan, M. (2021). Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, . Journal of chemotherapy (Florence, Italy), 33(8), 582-594. https://doi.org/10.1080/1120009X.2021.1924935
Ranjithkumar, R, et al. "Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, ." Journal of chemotherapy (Florence, Italy) vol. 33,8 (2021): 582-594. doi: https://doi.org/10.1080/1120009X.2021.1924935
Ranjithkumar R, Saravanan K, Balaji B, Hima S, Sreeja S, Timane SR, Ram Pravin Kumar M, Kabilan S, Ramanathan M. Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, . J Chemother. 2021 Dec;33(8):582-594. doi: 10.1080/1120009X.2021.1924935. Epub 2021 Jun 01. PMID: 34060437.
Copy Download .nbib Format: NLM
Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis.

Journal of chemotherapy (Florence, Italy)

Hua Q, Xu G, Zhao L, Zhang T.
PMID: 33501892
J Chemother. 2021 Sep;33(5):319-327. doi: 10.1080/1120009X.2021.1873631. Epub 2021 Jan 27.

The objective of this study is to assess the effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma (STS) and provide a relative ranking of regimens for STS. We pooled the hazard ratios of overall survival (OS) and relapse...

Cite
Hua Q, Xu G, Zhao L, et al. Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. J Chemother. 2021;33(5):319-327doi: 10.1080/1120009X.2021.1873631.
Hua, Q., Xu, G., Zhao, L., & Zhang, T. (2021). Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. Journal of chemotherapy (Florence, Italy), 33(5), 319-327. https://doi.org/10.1080/1120009X.2021.1873631
Hua, Qingling, et al. "Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis." Journal of chemotherapy (Florence, Italy) vol. 33,5 (2021): 319-327. doi: https://doi.org/10.1080/1120009X.2021.1873631
Hua Q, Xu G, Zhao L, Zhang T. Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis. J Chemother. 2021 Sep;33(5):319-327. doi: 10.1080/1120009X.2021.1873631. Epub 2021 Jan 27. PMID: 33501892.
Copy Download .nbib Format: NLM
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis.

Journal of chemotherapy (Florence, Italy)

Filippi R, Leone F, Fornaro L, Aprile G, Casadei-Gardini A, Silvestris N, Palloni A, Satolli MA, Scartozzi M, Russano M, Lutrino SE, Lombardi P, Frega G, Garattini SK, Vivaldi C, Spadi R, Giulia O, Fenocchio E, Brunetti O, Aglietta M, Brandi G.
PMID: 34313188
J Chemother. 2021 Jul 27;1-10. doi: 10.1080/1120009X.2021.1953887. Epub 2021 Jul 27.

Advanced biliary tract cancer (aBTC) comprises a heterogeneous group of rare malignancies with dismal prognosis. Given the scarcity of prospective evidence, the aim of this study was to derive clinically useful insights and prognostic factors from a large, real-world...

Cite
Filippi R, Leone F, Fornaro L, et al. Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. J Chemother. 2021;1-10doi: 10.1080/1120009X.2021.1953887.
Filippi, R., Leone, F., Fornaro, L., Aprile, G., Casadei-Gardini, A., Silvestris, N., Palloni, A., Satolli, M. A., Scartozzi, M., Russano, M., Lutrino, S. E., Lombardi, P., Frega, G., Garattini, S. K., Vivaldi, C., Spadi, R., Giulia, O., Fenocchio, E., Brunetti, O., Aglietta, M., & Brandi, G. (2021). Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. Journal of chemotherapy (Florence, Italy), 1-10. https://doi.org/10.1080/1120009X.2021.1953887
Filippi, Roberto, et al. "Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis." Journal of chemotherapy (Florence, Italy) vol. (2021): 1-10. doi: https://doi.org/10.1080/1120009X.2021.1953887
Filippi R, Leone F, Fornaro L, Aprile G, Casadei-Gardini A, Silvestris N, Palloni A, Satolli MA, Scartozzi M, Russano M, Lutrino SE, Lombardi P, Frega G, Garattini SK, Vivaldi C, Spadi R, Giulia O, Fenocchio E, Brunetti O, Aglietta M, Brandi G. Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. J Chemother. 2021 Jul 27;1-10. doi: 10.1080/1120009X.2021.1953887. Epub 2021 Jul 27. PMID: 34313188.
Copy Download .nbib Format: NLM
Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS .

Journal of chemotherapy (Florence, Italy)

Huang Z, Huang L, Liu L, Wang L, Lin W, Zhu X, Su W, Lv C, Moore N, Salter A, Tamboukou M.
PMID: 33764270
J Chemother. 2021 Sep;33(5):328-341. doi: 10.1080/1120009X.2021.1899441. Epub 2021 Mar 25.

Clinical studies have reported that miRNAs abnormal expression are associated with the generation of cisplatin-resistant to osteosarcoma. Our previous research found that miR-203 is downregulated in osteosarcoma cells and overexpressed miR-203 exerts antitumor properties on osteosarcoma cells. However, the...

Cite
Huang Z, Huang L, Liu L, et al. Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS . J Chemother. 2021;33(5):328-341doi: 10.1080/1120009X.2021.1899441.
Huang, Z., Huang, L., Liu, L., Wang, L., Lin, W., Zhu, X., Su, W., Lv, C., Moore, N., Salter, A., & Tamboukou, M. (2021). Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS . Journal of chemotherapy (Florence, Italy), 33(5), 328-341. https://doi.org/10.1080/1120009X.2021.1899441
Huang, Zhengxiang, et al. "Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS ." Journal of chemotherapy (Florence, Italy) vol. 33,5 (2021): 328-341. doi: https://doi.org/10.1080/1120009X.2021.1899441
Huang Z, Huang L, Liu L, Wang L, Lin W, Zhu X, Su W, Lv C, Moore N, Salter A, Tamboukou M. Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS . J Chemother. 2021 Sep;33(5):328-341. doi: 10.1080/1120009X.2021.1899441. Epub 2021 Mar 25. PMID: 33764270.
Copy Download .nbib Format: NLM
miR-302a-3p suppresses melanoma cell progression via targeting METTL3.

Journal of chemotherapy (Florence, Italy)

Chang X, Lin YY, Bai LN, Zhu W.
PMID: 34286671
J Chemother. 2021 Jul 21;1-12. doi: 10.1080/1120009X.2021.1953886. Epub 2021 Jul 21.

The miRNA-302 family plays a critical role in carcinogenesis. As an enzyme that regulates the N6-methyladenosine modification, methyltransferase-like 3 (METTL3) plays important roles in the development and progression of various tumours. However, the upstream regulatory mechanisms of METTL3 in...

Cite
Chang X, Lin YY, Bai LN, et al. miR-302a-3p suppresses melanoma cell progression via targeting METTL3. J Chemother. 2021;1-12doi: 10.1080/1120009X.2021.1953886.
Chang, X., Lin, Y. Y., Bai, L. N., & Zhu, W. (2021). miR-302a-3p suppresses melanoma cell progression via targeting METTL3. Journal of chemotherapy (Florence, Italy), 1-12. https://doi.org/10.1080/1120009X.2021.1953886
Chang, Xiao, et al. "miR-302a-3p suppresses melanoma cell progression via targeting METTL3." Journal of chemotherapy (Florence, Italy) vol. (2021): 1-12. doi: https://doi.org/10.1080/1120009X.2021.1953886
Chang X, Lin YY, Bai LN, Zhu W. miR-302a-3p suppresses melanoma cell progression via targeting METTL3. J Chemother. 2021 Jul 21;1-12. doi: 10.1080/1120009X.2021.1953886. Epub 2021 Jul 21. PMID: 34286671.
Copy Download .nbib Format: NLM
The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience.

Journal of chemotherapy (Florence, Italy)

Kolarov Bjelobrk I, Radic J, Trifunovic J, Pesic J, Vidovic V, Vranjkovic B, Petrovic N, Andrejic Visnjic B.
PMID: 34844517
J Chemother. 2021 Nov 30;1-8. doi: 10.1080/1120009X.2021.2009722. Epub 2021 Nov 30.

The choice of the anti-HER2 agent depends on country-specific availability, the specific, previously administered anti-HER2 therapy and the relapse-free interval, although there is not much published data on the use of lapatinib after progression on pertuzumab and/or T-DM1. The...

Cite
Kolarov Bjelobrk I, Radic J, Trifunovic J, et al. The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience. J Chemother. 2021;1-8doi: 10.1080/1120009X.2021.2009722.
Kolarov Bjelobrk, I., Radic, J., Trifunovic, J., Pesic, J., Vidovic, V., Vranjkovic, B., Petrovic, N., & Andrejic Visnjic, B. (2021). The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience. Journal of chemotherapy (Florence, Italy), 1-8. https://doi.org/10.1080/1120009X.2021.2009722
Kolarov Bjelobrk, Ivana, et al. "The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience." Journal of chemotherapy (Florence, Italy) vol. (2021): 1-8. doi: https://doi.org/10.1080/1120009X.2021.2009722
Kolarov Bjelobrk I, Radic J, Trifunovic J, Pesic J, Vidovic V, Vranjkovic B, Petrovic N, Andrejic Visnjic B. The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience. J Chemother. 2021 Nov 30;1-8. doi: 10.1080/1120009X.2021.2009722. Epub 2021 Nov 30. PMID: 34844517.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 146 entries